Figure 2From: Use of serum squamous cell carcinoma antigen for follow-up monitoring of cervical cancer patients who were treated by concurrent chemoradiotherapyReceiver operating characteristic curve for ΔSCC-Ag in predicting the probability of a recurrence in all patients.Back to article page